Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/27932
Title: Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil
Authors: Yoshioka, MCN
Alchorne, MMD
Porro, A. M.
Tomimori-Yamashita, J.
Universidade Federal de São Paulo (UNIFESP)
Issue Date: 1-Sep-2004
Publisher: Blackwell Publishing Ltd
Citation: International Journal of Dermatology. Oxford: Blackwell Publishing Ltd, v. 43, n. 9, p. 643-647, 2004.
Abstract: Background Kaposi's sarcoma (KS) is the most frequent neoplasm in patients with acquired immunodeficiency syndrome (AIDS). Although many studies on KS epidemiology have been performed in other countries, few have been carried out in Brazil despite the high incidence of AIDS.Methods One hundred and seven KS patients seen in São Paulo, Brazil, between August 1995 and November 1998 were studied. the patients were followed for 1 year with assessment of the immunologic status, improvement of the lesions, treatment, and causes of death at the end of this period.Results KS occurred mainly in men (94.4%) with a mean age of 37 years, and 25.2% of these patients were found to be human immunodeficiency virus (HIV) seropositive through KS. HIV was acquired mainly through homosexual contact. the patients presented an average of 15.9 KS lesions at the first visit and the mean duration of KS lesions before the first visit was 15.5 months. the clinical presentation was predominantly papules and plaques, and 33.6% presented with mucosal and/or visceral disease. KS affected mainly the lower limbs. the mean time since the diagnosis of HIV infection was 42.4 months. the CD4+ cell count was lower than 200 cell/mm(3) in 60.8% of patients, but patients with a complete response showed an improvement in immune status after 1 year. Patients who did not show progression received a protease inhibitor as part of highly active antiretroviral therapy (HAART). Patients treated exclusively with HAART presented a complete response (61.6%), partial response (23%) or progression (15.4%) of KS.Conclusions An improvement in immune status and the use of HAART were the most important prognostic features.
URI: http://repositorio.unifesp.br/handle/11600/27932
ISSN: 0011-9059
Other Identifiers: http://dx.doi.org/10.1111/j.1365-4632.2004.02170.x
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.